LY 03006
Alternative Names: LY-03006Latest Information Update: 24 Nov 2015
At a glance
- Originator Luye Pharma Group
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders